Health
The Business Case Behind Feeding Cancer Patients Right
Oncology nutrition demand is rising as cancer care formalizes nutritional support, reinforcing established medical nutrition manufacturers' market positions.
20 days ago
Grief Meets Science: Private Autopsy Demand Grows
Colorado firm Postmortem Pathology sees rising demand from families seeking independent autopsies after coroner findings leave questions unanswered.
22 days ago
AI Drug Discovery Clears First Real-World Test
Noetik has cleared the first milestone in its multi-year AI oncology collaboration with GSK, an early test of AI-driven drug discovery.
24 days ago
Ultrasound Market Bets Big on Handheld Devices
Global ultrasound devices market set to grow from $10.9B to $18.0B by 2036 as portable, AI-enabled systems reshape diagnostics.
27 days ago
Bleeding-Control Device Market Set to Hit $4.67bn
Hemorrhage control device sales are forecast to reach $4.67 billion by 2030, driven by trauma care, military and maternal-health demand.
about 1 month ago
Free App Bets Health Data Beats the Needle
January AI's updated app merges medical records, wearable data, and CGM-free glucose prediction, free of charge—a first for digital health.
about 2 months ago
Hospital Care Goes Remote: AI Enters the Home
Vega Health and Baptist Health partner to bring AI-driven monitoring insights to hospital-at-home care, aiming for a lasting collaboration.
2 months ago
Frozen Platelets Target a Persistent Lab Supply Gap
Retham Technologies launches cryopreserved research platelets, with Prolytix as distributor, addressing platelets' notoriously short usable life.
2 months ago
RoenRx Details 2026 Weight-Loss Program Pricing: A Comprehensive Financial Guide to Telehealth GLP-1 Treatments
RoenRx has released its detailed 2026 pricing for medically supervised weight-loss programs, including transparent costs for GLP-1 treatments (brand-name and compounded), various membership options, and all-inclusive bundled care plans, emphasizing accessibility and professional support.
3 months ago
New Research Institute Launched to Advance Early Biology of Breast Cancer in Young Women
The Breast Cancer in Young Women Foundation has announced the launch of the Young Women's Breast Cancer Research Institute — the first-of-its-kind scientific body dedicated to understanding why breast cancer develops early in some women, with a central focus on the biological changes that occur before a tumour ever appears.
3 months ago
Vaxart Directors Outline Strategy for Shareholder Value Ahead of 2026 Meeting
Vaxart's newest independent directors sent a letter to shareholders outlining their commitment to enhancing value, governance, and oral vaccine development.
3 months ago
Curaechoice Partners with Capitol Imaging for No-Cost Diagnostic Access
Curaechoice partners with Capitol Imaging Services to offer no-cost diagnostic imaging for its members, enhancing access to critical medical scans and reducing financial burdens.
3 months ago
Manassas Chiropractor Adopts Low-Force Adjusting Methods
Manassas chiropractor Dr. Gyzel Tabrizi uses low-force instrument adjusting techniques, offering a gentle yet precise alternative for spinal and joint care.
3 months ago
TNBC Clinical Trial Report Reveals Active Pipeline
DelveInsight's new report reveals over 350 active global clinical trials for Triple-Negative Breast Cancer, with immunotherapies and ADCs leading new treatments. North America holds the most studies.
4 months ago
Sensei Biotherapeutics Expands Team with Stock Grants
Sensei Biotherapeutics issued inducement stock options to three new employees under Nasdaq rules to attract key talent for its immunooncology pipeline.
4 months ago
Entrada Therapeutics Issues Inducement Grants to New Hires
Entrada Therapeutics announced inducement stock options for 32,500 shares to new employees, adhering to Nasdaq Listing Rule 5635(c)(4).
4 months ago
Revelation Biosciences Bolsters Kidney Injury Board
Revelation Biosciences expanded its Acute Kidney Injury Advisory Board with two new experts to guide the clinical development of its lead asset, REV-002.
4 months ago
Genentech to Unveil Obesity Data at ADA 2026
Genentech will present new data on its obesity portfolio, including GDC-9413 and GDC-7817, at the 2026 ADA Scientific Sessions. A new discovery program is also planned.
4 months ago